PRESS RELEASE published on 11/05/2024 at 10:02, 1 year 9 months ago EQS-Adhoc: PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as Chief Executive Officer PharmaSGP Holding SE appoints Peter Gerckens as new CEO, succeeding Natalie Weigand. Gerckens, currently CCO, will assume the CEO position on January 1, 2025 Supervisory Board PharmaSGP Holding SE CEO Succession Peter Gerckens Natalie Weigand
BRIEF published on 10/01/2024 at 08:20, 1 year 10 months ago PharmaSGP Holding SE acquiert 477 701 actions par le biais d'une offre de rachat Actions Propres Rachat D'actions Réduction De Capital Offre De Rachat PharmaSGP
BRIEF published on 10/01/2024 at 08:20, 1 year 10 months ago PharmaSGP Holding SE Acquires 477,701 Shares Through Repurchase Offer Share Buyback Treasury Shares Capital Reduction PharmaSGP Repurchase Offer
PRESS RELEASE published on 10/01/2024 at 08:15, 1 year 10 months ago PharmaSGP Holding SE has purchased 477,701 own shares through its public share repurchase offer PharmaSGP Holding SE has purchased 477,701 own shares through public share repurchase offer. The company's acceptance ratio is approximately 80.37% Share Buyback Treasury Shares Public Offer PharmaSGP Holding Acceptance Ratio
BRIEF published on 09/12/2024 at 08:20, 1 year 10 months ago PharmaSGP poursuit sa croissance dynamique au premier semestre 2024 Expansion Internationale Croissance Des Revenus Résultats Financiers 2024 PharmaSGP Produits Pharmaceutiques En Vente Libre
BRIEF published on 09/12/2024 at 08:20, 1 year 10 months ago PharmaSGP Continues Dynamic Growth Path in First Half of 2024 Revenue Growth International Expansion PharmaSGP OTC Pharmaceuticals 2024 Financials
BRIEF published on 09/12/2024 at 08:15, 1 year 10 months ago PharmaSGP Holding SE annonce un programme de rachat d'actions Rachat D'actions PharmaSGP Holding SE Période D'acceptation 594 405 Partages 21,45 EUR
BRIEF published on 09/12/2024 at 08:15, 1 year 10 months ago PharmaSGP Holding SE Announces Share Repurchase Program Share Repurchase Acceptance Period PharmaSGP Holding SE 594,405 Shares EUR 21.45
PRESS RELEASE published on 09/12/2024 at 08:15, 1 year 10 months ago PharmaSGP continues dynamic growth path in the first half of 2024 PharmaSGP Holding SE reports dynamic growth with half-year revenues reaching €58.4 million, up 17.4% from last year. Management expects full-year revenues to range from €107.0m to €112.0m Revenues Germany Growth Internationalization PharmaSGP
PRESS RELEASE published on 09/12/2024 at 08:10, 1 year 10 months ago EQS-Adhoc: PharmaSGP Holding SE resolves on public share repurchase offer to buy back own shares for up to 594,405 shares PharmaSGP Holding SE announces public share repurchase offer to buy back own shares for up to 594,405 shares, with acceptance period from September 13 to 26, 2024 Acceptance Period 2024 PharmaSGP Holding SE 594,405 Shares Share Repurchase Offer
Published on 08/11/2026 at 07:00, 1 hour 41 minutes ago Alaska Energy Metals Announces Closing of Shares for Debt Settlement
Published on 08/11/2026 at 00:40, 8 hours 1 minute ago CORRECTION FROM SOURCE: Fermi Announces Binding Lease Agreement with TensorWave
Published on 08/11/2026 at 00:25, 8 hours 16 minutes ago Empress Reports 2026 Second Quarter Financial Results
Published on 08/10/2026 at 23:35, 9 hours 6 minutes ago NioCorp Project to Expand Production to 8 Made-in-USA Critical Minerals Over a 40-Year Mine Life with an Estimated $4.1 Billion Pre-Tax NPV8%
Published on 08/10/2026 at 23:30, 9 hours 11 minutes ago Condor and Element79 Agree on Restructured Terms for Lucero Project
Published on 08/11/2026 at 08:30, 11 minutes ago Energiekontor AG: Energiekontor optimises wind parks with Smart Windfarm Controller
Published on 08/11/2026 at 08:05, 36 minutes ago LX Pantos Strengthens Global ESG Leadership Through Its 2026 Sustainability Report
Published on 08/11/2026 at 08:00, 41 minutes ago Cairn Homes Plc: Appointment of Pat Farrell as Independent Non-Executive Director
Published on 08/11/2026 at 08:00, 41 minutes ago CANCOM SE continues to significantly strengthen profitability in H1.26
Published on 08/10/2026 at 18:00, 14 hours 41 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 14 hours 41 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 14 hours 56 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 08/10/2026 at 11:53, 20 hours 47 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
